Zhejiang Hisoar Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Hisoar Pharmaceutical Co Ltd financial flexibility index. Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥31.99 Million (operating CF CN¥15.48 Million minus capex CN¥16.52 Million) represents 0% of total liabilities (CN¥2.17 Billion). Explore Zhejiang Hisoar Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Financial flexibility index of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. Historical Financial Flexibility Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 22 annual periods. Check Zhejiang Hisoar Pharmaceutical Co Ltd (002099) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Hisoar Pharmaceutical Co Ltd Financial Flexibility Index by Year (2003–2024)
Zhejiang Hisoar Pharmaceutical Co Ltd financial flexibility index by year from 2003 to 2024. Year-by-year free cash flow to debt coverage for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Hisoar Pharmaceutical Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥296.94 Million | CN¥174.83 Million | CN¥2.32 Billion | ▼ -37.7% |
| 2023 | 0.21x | CN¥393.61 Million | CN¥240.54 Million | CN¥1.92 Billion | ▲ +58.9% |
| 2022 | 0.13x | CN¥295.52 Million | CN¥116.09 Million | CN¥2.29 Billion | ▼ -25.8% |
| 2021 | 0.17x | CN¥331.92 Million | CN¥102.36 Million | CN¥1.91 Billion | ▼ -62.0% |
| 2020 | 0.46x | CN¥608.05 Million | CN¥533.87 Million | CN¥1.33 Billion | ▼ -39.4% |
| 2019 | 0.76x | CN¥773.04 Million | CN¥612.40 Million | CN¥1.02 Billion | ▲ +18.7% |
| 2018 | 0.64x | CN¥1.05 Billion | CN¥791.45 Million | CN¥1.64 Billion | ▲ +488.2% |
| 2017 | 0.11x | CN¥251.67 Million | CN¥102.68 Million | CN¥2.32 Billion | ▼ -69.3% |
| 2016 | 0.35x | CN¥753.73 Million | CN¥629.42 Million | CN¥2.14 Billion | ▼ -41.5% |
| 2015 | 0.60x | CN¥758.52 Million | CN¥462.16 Million | CN¥1.26 Billion | ▲ +65.3% |
| 2014 | 0.36x | CN¥360.62 Million | CN¥191.56 Million | CN¥988.73 Million | ▲ +57.2% |
| 2013 | 0.23x | CN¥342.64 Million | CN¥60.85 Million | CN¥1.48 Billion | ▼ -54.9% |
| 2012 | 0.51x | CN¥607.51 Million | CN¥180.73 Million | CN¥1.18 Billion | ▲ +15.9% |
| 2011 | 0.44x | CN¥310.14 Million | CN¥92.62 Million | CN¥698.17 Million | ▼ -31.8% |
| 2010 | 0.65x | CN¥327.39 Million | CN¥180.88 Million | CN¥502.28 Million | ▲ +86.3% |
| 2009 | 0.35x | CN¥151.98 Million | CN¥98.38 Million | CN¥434.48 Million | ▲ +34.6% |
| 2008 | 0.26x | CN¥121.01 Million | CN¥30.61 Million | CN¥465.58 Million | ▼ -34.7% |
| 2007 | 0.40x | CN¥163.75 Million | CN¥51.14 Million | CN¥411.69 Million | ▼ -2.6% |
| 2006 | 0.41x | CN¥164.47 Million | CN¥61.88 Million | CN¥402.66 Million | ▲ +46.5% |
| 2005 | 0.28x | CN¥109.81 Million | CN¥36.07 Million | CN¥393.76 Million | ▼ -16.1% |
| 2004 | 0.33x | CN¥84.90 Million | CN¥42.36 Million | CN¥255.35 Million | ▲ +139.6% |
| 2003 | 0.14x | CN¥38.48 Million | CN¥-5.45 Million | CN¥277.36 Million | — |